Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-382,142
Closed -$28.9M 1319
2026
Q1
$28.9M Buy
382,142
+96,400
+34% +$7.25M 0.2% 140
2025
Q4
$21.3M Buy
+285,742
New +$20.9M 0.14% 186
2023
Q2
Sell
-2,830
Closed -$228K 1146
2023
Q1
$228K Sell
2,830
-600
-17% -$48.3K ﹤0.01% 1021
2022
Q4
$257K Sell
3,430
-615
-15% -$43.8K ﹤0.01% 1032
2022
Q3
$261K Hold
4,045
﹤0.01% 1096
2022
Q2
$280K Hold
4,045
﹤0.01% 1125
2022
Q1
$311K Buy
+4,045
New +$291K ﹤0.01% 1150

Other funds holding HOLX

Gabelli Funds's HOLX Position: Q2 2026 in Review

Gabelli Funds sold out of Hologic (HOLX) in Q2 2026, closing a stake of 382,142 shares — an estimated $28.9M sold.

Gabelli Funds first reported a position in HOLX in Q1 2022 and held it in 7 quarters. The position peaked at $28.9M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Gabelli Funds reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Gabelli Funds sold 382,142 Hologic shares in Q2 2026, an estimated $28.9M.
  • Gabelli Funds first reported a position in Hologic in Q1 2022 and held it in 7 quarters.
  • Gabelli Funds's Hologic position peaked at $28.9M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.